These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21094903

  • 1. Structural basis for ligand recognition of incretin receptors.
    Underwood CR, Parthier C, Reedtz-Runge S.
    Vitam Horm; 2010; 84():251-78. PubMed ID: 21094903
    [Abstract] [Full Text] [Related]

  • 2. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA, McIntosh CH.
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [Abstract] [Full Text] [Related]

  • 3. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
    Moon MJ, Kim HY, Kim SG, Park J, Choi DS, Hwang JI, Seong JY.
    Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
    [Abstract] [Full Text] [Related]

  • 4. Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.
    Moon MJ, Kim HY, Park S, Kim DK, Cho EB, Park CR, You DJ, Hwang JI, Kim K, Choe H, Seong JY.
    J Biol Chem; 2012 Feb 03; 287(6):3873-84. PubMed ID: 22105074
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
    Underwood CR, Garibay P, Knudsen LB, Hastrup S, Peters GH, Rudolph R, Reedtz-Runge S.
    J Biol Chem; 2010 Jan 01; 285(1):723-30. PubMed ID: 19861722
    [Abstract] [Full Text] [Related]

  • 6. Insights into the structure and activation mechanism of some class B1 GPCR family members.
    Aksu H, Demirbilek A, Uba AI.
    Mol Biol Rep; 2024 Sep 06; 51(1):966. PubMed ID: 39240462
    [Abstract] [Full Text] [Related]

  • 7. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling.
    Malde AK, Srivastava SS, Coutinho EC.
    J Pept Sci; 2007 May 06; 13(5):287-300. PubMed ID: 17437246
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.
    Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D, Fanghänel J, Rahfeld JU, Demuth HU, Stubbs MT.
    Proc Natl Acad Sci U S A; 2007 Aug 28; 104(35):13942-7. PubMed ID: 17715056
    [Abstract] [Full Text] [Related]

  • 9. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
    Volz A, Göke R, Lankat-Buttgereit B, Fehmann HC, Bode HP, Göke B.
    FEBS Lett; 1995 Oct 02; 373(1):23-9. PubMed ID: 7589426
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH, Yin Y, Yang D, Liu B, Hou L, Wang X, Pal K, Jiang Y, Feng Y, Cai X, Dai A, Liu M, Wang MW, Melcher K, Xu HE.
    J Biol Chem; 2016 Jul 15; 291(29):15119-30. PubMed ID: 27226600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced diabetes type 2: In silico study involving class B GPCRs.
    Latek D, Rutkowska E, Niewieczerzal S, Cielecka-Piontek J.
    PLoS One; 2019 Jul 15; 14(1):e0208892. PubMed ID: 30650080
    [Abstract] [Full Text] [Related]

  • 15. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T, Drucker DJ.
    Regul Pept; 2005 Jun 15; 128(2):125-34. PubMed ID: 15780432
    [Abstract] [Full Text] [Related]

  • 16. Structure of the glucagon receptor in complex with a glucagon analogue.
    Zhang H, Qiao A, Yang L, Van Eps N, Frederiksen KS, Yang D, Dai A, Cai X, Zhang H, Yi C, Cao C, He L, Yang H, Lau J, Ernst OP, Hanson MA, Stevens RC, Wang MW, Reedtz-Runge S, Jiang H, Zhao Q, Wu B.
    Nature; 2018 Jan 03; 553(7686):106-110. PubMed ID: 29300013
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
    Bhat VK, Kerr BD, Flatt PR, Gault VA.
    Biochem Pharmacol; 2013 Jun 01; 85(11):1655-62. PubMed ID: 23518155
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA, Bergmann NC, Knop FK.
    Diabetes Obes Metab; 2016 Sep 01; 18(9):847-54. PubMed ID: 27160961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.